6-30948970-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_080870.4(MUCL3):c.506G>A(p.Arg169His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000838 in 1,551,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_080870.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MUCL3 | NM_080870.4 | c.506G>A | p.Arg169His | missense_variant | 2/3 | ENST00000462446.6 | |
HCG21 | NR_138040.1 | n.257-2392C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MUCL3 | ENST00000462446.6 | c.506G>A | p.Arg169His | missense_variant | 2/3 | 5 | NM_080870.4 | A2 | |
HCG21 | ENST00000419481.1 | n.225-2611C>T | intron_variant, non_coding_transcript_variant | 3 | |||||
MUCL3 | ENST00000636043.1 | c.707G>A | p.Arg236His | missense_variant | 5/6 | 5 | P4 | ||
SFTA2 | ENST00000634371.1 | c.-9+3392C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000651 AC: 1AN: 153602Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81536
GnomAD4 exome AF: 0.00000786 AC: 11AN: 1399258Hom.: 0 Cov.: 30 AF XY: 0.00000580 AC XY: 4AN XY: 690130
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74462
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at